04:16:08 EDT Fri 19 Apr 2019
Enter Symbol
or Name

Login ID:
Cardiocomm Solutions Inc (2)
Symbol C : EKG
Shares Issued 137,213,815
Close 2018-11-08 C$ 0.04
Recent Sedar Documents

Cardiocomm hires Agoracom for on-line marketing

2018-11-08 20:17 ET - News Release

Mr. Etienne Grima reports


Cardiocomm Solutions Inc. is implementing an on-line marketing and awareness program through Agora Internet Relations Corp. (Agoracom).

Agoracom's program will provide the company a significant level of exposure through millions of content brand insertions on the Agoracom network and extensive search engine marketing over the next 12 months. In addition, exclusive sponsorships through digital properties such as Agoracom TV, website and social media channels will be used to significantly raise the brand awareness of the company among small-cap investors.

Agoracom's chief executive officer, George Tsiolis, confirms: "We have been tracking Cardiocomm for the past six years and are very impressed with both the company's product releases and changes to fiscal performance. As an FDA-cleared, ISO-certified and Health Canada/CE-approved company, their advances in ECG monitoring and reporting between patients, doctors and hospitals are incredible. This is a story that small-cap investors need to know, and Agoracom is excited about the opportunity to tell it for the purposes of expanding Cardiocomm's investor awareness far beyond where it is today. We expect to launch the program around Nov. 15 and invite current shareholders to re-engage with the company on its fully moderated discussion forum at that time."

Under the agreement, which is subject to TSX Venture Exchange approval, the company will issue common shares of the company for services to Agoracom in exchange for on-line advertising, marketing and branding services. Pursuant to the terms of the agreement, the company will be issuing an aggregate of $50,000 worth of shares, plus HST, for advertising services, in $10,000 allotments as follows:

  • Following approval of the agreement by the TSX Venture Exchange, for initial set-up, marketing materials and search engine programs;
  • At the completion of each three-month period ending Feb. 7, 2019, May 7, 2019, Aug. 7, 2019, and Nov. 7, 2019.

The number of shares to be issued at the end of each period will be determined by using the closing price of the shares on the TSX Venture Exchange on the first trading day following each period for which the advertising services were provided by Agoracom. The term of the agreement is for 12 months effective immediately.

The company also announced that it issued 187,500 stock options to Etienne Grima, the company's CEO, in accordance with his employment agreement. The options are exercisable at five cents per share for five years from the date of grant and vest immediately. The grants are subject to the provisions of the company's stock option plan, the policies of the TSX Venture Exchange and applicable securities laws.

About Cardiocomm Solutions Inc.

Cardiocomm Solutions' patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team.

We seek Safe Harbor.

© 2019 Canjex Publishing Ltd. All rights reserved.